文献速递糖尿病

青少年起病2型糖尿病的心率变异性与心脏自主神经功能障碍:患病率、危险因素及与动脉僵硬度的关系

Heart Rate Variability and Cardiac Autonomic Dysfunction: Prevalence, Risk Factors, and Relationship to Arterial Stiffness in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.
PubMed 文献 · Diabetes Care · 2019-09-09

本研究基于TODAY研究,评估青少年起病2型糖尿病年轻成人中先前降糖治疗或长期血糖控制与心率变异性(HRV)的独立关联,以及心脏自主神经功能障碍与动脉僵硬度的关系。共397名参与者在随机化后7年接受评估,结果显示HRV降低、副交感神经损失和交感神经过度驱动,8%存在心脏自主神经功能障碍且与脉搏波速度增高相关;HRV与随机治疗无关,但较高的HbA1c独立关联更低的SDNN和RMSSD及更高的LF:HF比值。

要点

  • 青少年起病2型糖尿病年轻成人HRV降低,表现为副交感神经损失和交感神经过度驱动。
  • 8%的参与者存在心脏自主神经功能障碍,且与更高的脉搏波速度相关。
  • 较高的HbA1c独立关联更低的SDNN和RMSSD及更高的LF:HF比值。

核心结论

  • 青少年起病2型糖尿病年轻成人存在心脏自主神经功能障碍,表现为副交感和交感神经损害,且与较高的HbA1c相关。

研究设计与样本

  • TODAY研究的队列分析,共397名参与者,在随机化后7年进行10分钟心跳测量以推导NN间期相关指标。

主要发现

  • TODAY参与者SDNN为58.1 ± 29.6 ms,低于对照组的67.1 ± 25.4 ms(P < 0.0001)。
  • TODAY参与者RMSSD为53.2 ± 36.7 ms,低于对照组的67.9 ± 35.2 ms(P < 0.0001)。
  • TODAY参与者LF:HF比值为1.4 ± 1.7,高于对照组的1.0 ± 1.1(P < 0.0001)。
  • 8%的TODAY参与者存在心脏自主神经功能障碍,且这些参与者脉搏波速度更高(P = 0.0001)。
  • HRV与随机治疗无关,但较高的HbA1c独立关联更低的SDNN和RMSSD及更高的LF:HF比值。

关键数值与推荐

  • 心脏自主神经功能障碍定义为5项HRV指标中至少3项异常(与另一项研究的肥胖对照相比)。

临床怎么用

  • 对青少年起病2型糖尿病年轻成人,应关注心率变异性评估以识别心脏自主神经功能障碍。
  • 长期血糖控制(较高的HbA1c)与心脏自主神经功能障碍独立相关,提示优化血糖管理可能有益。
  • 心脏自主神经功能障碍与动脉僵硬度增加相关,需综合评估心血管风险。

局限性

  • HRV异常的定义基于另一项研究的肥胖对照,而非本研究内对照。
  • 研究为观察性分析,无法确定因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether prior type 2 diabetes (T2D) treatment or glycemic control over time are independently associated with heart rate variability (HRV) and whether the presence of cardiac autonomic dysfunction is associated with arterial stiffness in young adults with youth-onset T2D enrolled in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study. RESEARCH DESIGN AND METHODS: Heartbeats over 10 min were measured to derive the normal R-Rs (NN intervals). Outcomes included the standard deviation of the NN intervals (SDNN), the root mean square differences of successive NN intervals (RMSSD), percent of NN beats that differ by more than 50 ms (PNN50), and the low-frequency (LF) power domain, high-frequency (HF) power domain, and their ratio (LF:HF). Autonomic dysfunction was defined as ≥3 of 5 abnormal HRV indices compared with obese controls from a separate study. RESULTS: A total of 397 TODAY participants were evaluated 7 years after randomization. TODAY participants had reduced HRV (SDNN 58.1 ± 29.6 ms vs. controls 67.1 ± 25.4 ms; P < 0.0001) with parasympathetic loss (RMSSD 53.2 ± 36.7 ms vs. controls 67.9 ± 35.2 ms; P < 0.0001) with sympathetic overdrive (LF:HF ratio 1.4 ± 1.7 vs. controls 1.0 ± 1.1; P < 0.0001). Cardiac autonomic dysfunction was present in 8% of TODAY participants, and these participants had greater pulse wave velocity compared with those without dysfunction (P = 0.0001). HRV did not differ by randomized treatment, but higher hemoglobin A1c (HbA1c) over time was independently associated with lower SDNN and RMSSD and higher LF:HF ratio after adjustment for age, race-ethnicity, sex, and BMI. CONCLUSIONS: Young adults with youth-onset T2D show evidence of cardiac autonomic dysfunction with both parasympathetic and sympathetic impairments that are associated with higher HbA1c.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Shah AS, El Ghormli L, Vajravelu ME, et al. Heart Rate Variability and Cardiac Autonomic Dysfunction: Prevalence, Risk Factors, and Relationship to Arterial Stiffness in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. Diabetes Care. 2019. PMID: 31501226. doi:10.2337/dc19-0993

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。